Andrea Capponi

Dr. Andrea Capponi


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2025 in Diagnostics
Verified
Journal Article
Open access
Andrea CapponiAndrea Capponi
Andrea Capponi
CRcarlo rostagno
carlo rostagno
Trauma remains a leading cause of death and disability in adults, and about 20% of deaths occur due to intractable bleeding. Trauma-induced coagulopathy (TIC) is a complex hemostatic disorder characterized by an abnormal coagulation response, which can manifest as either a hypo-coagulable state, leading to excessive bleeding, or a hypercoagulable state, resulting in thromboembolic events and multiple organ failure. Early diagnosis and correction of hypocoagulability may be lifesaving. Replacement of coagulation factors using blood components as well as counteracting enhanced fibrinolysis with tranexamic acid in association with a strategy of damage control are the current practices in the management of TIC. Nevertheless, the improved comprehension of the several mechanisms involved in the development of TIC might offer space for a tailored treatment with improvement of clinical outcome. This review aims to outline the pathophysiology of TIC and evaluate both established and emerging management strategies. A thorough literature review was made with a specific emphasis on articles discussing the molecular mechanisms of trauma-induced coagulopathy. We utilized PubMed, Scopus, and Web of Science with the main search terms “trauma-induced coagulopathy”, “molecular mechanisms”, and “coagulation pathways”.

1 January 2026 in World Journal of Emergency Medicine
Verified
Journal Article
Closed access
Andrea CapponiAndrea Capponi
Andrea Capponi
CRCarlo Rostagno
Carlo Rostagno

1 January 2025 in Annals of Circulation
Verified
Journal Article
Open access
PDF file
Andrea CapponiAndrea Capponi
Andrea Capponi
Trauma-induced coagulopathy (TIC) is a common early complication in major trauma, typically presented with prolonged PT and aPTT. However, isolated or disproportionate aPTT prolongation warrants consideration of alternative diagnoses, such as acquired hemophilia A, a rare autoimmune disorder marked by factor VIII inhibitors and severe bleeding. This case describes a young, previously healthy trauma patient whose presentation mimicked TIC but was ultimately diagnosed with acquired hemophilia A, requiring immunosuppressive therapy and bypassing agents. The case underscores the importance of maintaining a broad differential diagnosis for coagulopathy in trauma settings to ensure timely recognition and appropriate management of rare but life-threatening conditions.